Private Equity

  • April 16, 2026

    Katten Partner Rejoins Epstein Becker In DC For 3rd Time

    Epstein Becker Green LLP has rehired, for the third time, a healthcare transactional attorney who focuses his practice on guiding hospital systems, private equity-backed entities and professional practices on transactional matters and regulatory compliance.

  • April 16, 2026

    Davis Polk, Ropes & Gray Lead Defense Tech Firm Arxis' $1.1B IPO

    Bloomfield, Connecticut-based aerospace parts manufacturer Arxis said it raised $1.1 billion after pricing shares at the top of their range in a Thursday initial public offering advised by Davis Polk & Wardwell LLP and Ropes & Gray LLP.

  • April 16, 2026

    O'Melveny Adds M&A Duo From BakerHostetler In Dallas

    O'Melveny & Myers LLP announced Thursday that it has bulked up its mergers and acquisitions and private equity group with a pair of Dallas-based partners who came aboard from BakerHostetler, further strengthening the firm's growing presence in the Lone Star State.

  • April 15, 2026

    Ace Secures $228M Across 2 Flagship Funds Despite Volatility

    Global investment group Ace & Company on Wednesday revealed that it secured a total of $228 million of capital commitments across two of its flagship funds in the first quarter of the year, a feat that the firm said came during "significant" market volatility and "heightened" geopolitical uncertainty.

  • April 15, 2026

    Cvent Investors Reach $12M Deal To End Take-Private Suit

    Stockholders of cloud-based event management technology provider Cvent Holding Corp. have reached a $12 million settlement with the company, its top brass and its controlling shareholder over claims that they breached their fiduciary duties in connection with the company's $4.6 billion take-private sale to affiliates of Blackstone Inc.

  • April 15, 2026

    V&E, Kirkland Advise On $650M Natural Gas Storage Sale

    Spire Inc. said Wednesday it has agreed to sell its natural gas storage assets in Wyoming and Oklahoma to global infrastructure investor I Squared Capital for $650 million.

  • April 15, 2026

    White & Case Hires Reed Smith M&A Partner In DC

    White & Case LLP has hired a former Reed Smith LLP partner, who is joining the team in Washington, D.C., to continue her practice focused on mergers and acquisitions matters.

  • April 15, 2026

    Leo Says Missteps Sank $50M SpaceX Investment In Appeal

    The Delaware Supreme Court on Wednesday grappled with whether a fund manager's handling of a failed $50 million SpaceX investment crossed the line into fiduciary misconduct, as attorneys for both sides clashed over causation, fairness and a controversial $16 million fee award stemming from the dispute.

  • April 15, 2026

    Goodwin-Led Topspin Wraps $328M Consumer-Focused Fund

    Goodwin Procter LLP-advised private equity shop Topspin Consumer Partners on Wednesday revealed that it closed its third fund after securing $328 million in capital commitments.

  • April 15, 2026

    Sidley Adds Another NY Capital Markets Pro From Cravath

    Sidley Austin LLP announced Wednesday that it has hired another New York-based capital markets attorney from Cravath Swaine & Moore LLP, touting her history advising venture capital-backed companies, founders, investors and financial institutions on a range of corporate matters.

  • April 15, 2026

    Smaller Deals Drove US Private Equity In Q1 As Exits Slumped

    U.S. private equity dealmakers closed more transactions in the first quarter of 2026 than a year earlier but deployed less capital as exits plunged, signaling a shift to smaller deals amid heightened macroeconomic and geopolitical uncertainty.

  • April 14, 2026

    Armistice Capital Used COVID To Juice Vaxart Stock, Jury Told

    Hedge fund Armistice Capital and two of its executives exploited the COVID-19 pandemic to issue press releases that falsely inflated their controlling share in pharmaceutical company Vaxart, then dumped the shares for $250 million before the bottom fell out, investors told a California federal jury at the start of trial Tuesday.

  • April 14, 2026

    Trump's Fed Chair Pick Will Get Senate Hearing Next Week

    The Senate Banking Committee will meet next week to vet Kevin Warsh as President Donald Trump's nominee as the next leader of the Federal Reserve, moving forward with his confirmation process despite bipartisan protests over a still-pending probe of current Fed Chair Jerome Powell.

  • April 14, 2026

    Foundation Building Investors Ink $26M Deal Over PE Buyout

    The CEO, controlling investor and board members of specialty building product maker Foundation Building Materials Inc. and others have reached a $26 million settlement with stockholders who challenged the company's $1.4 billion sale to a private equity buyer on claims that the defendants breached their fiduciary duties.

  • April 14, 2026

    Red State AGs Fight Bid To Trim Suit Against BlackRock

    Republican attorneys general are opposing a bid by BlackRock and State Street to trim a suit accusing the asset managers of driving up coal prices, arguing that the firms' assertion that the suit cannot get past the U.S. Supreme Court's decision on federal antitrust damages claims is incorrect.

  • April 14, 2026

    Aluminum Parts Maker Strikes $2M Deal To End ESOP Lawsuit

    An aluminum components manufacturer will pay $2 million to resolve a proposed class action alleging it mismanaged its employee stock ownership plan by investing non-company assets too conservatively, according to a Tuesday filing in California federal court.

  • April 14, 2026

    3 Firms Guide TPG's Bet On College Sports Rights Giant

    Alternative asset manager TPG said Tuesday it has agreed to acquire Learfield, a leading college sports media and technology company, in a deal steered by three law firms. 

  • April 14, 2026

    Davis Polk-Led Lightyear Capital Raises $2.5B For 6th Fund

    Davis Polk & Wardwell LLP-advised middle market private equity shop Lightyear Capital on Tuesday announced that it closed its sixth fund at its hard cap after securing $2.5 billion of investor commitments.

  • April 14, 2026

    Eli Lilly To Purchase Cooley-Led CrossBridge In $300M Deal

    Venture-backed pre-clinical biotechnology firm CrossBridge Bio Inc., advised by Cooley LLP, on Tuesday announced that it has agreed to be bought by pharmaceutical giant Eli Lilly & Co. in a deal worth up to $300 million.

  • April 14, 2026

    OpenAI Says Musk Remedy Shift Leaves 'No Case Left To Try'

    OpenAI is pushing back after Elon Musk said he would seek to have Sam Altman removed as the artificial intelligence company's CEO in a case challenging its conversion to a for-profit entity, telling a California federal court that the last-minute change adds a host of issues just weeks before trial.

  • April 14, 2026

    Avanos Medical Going Private In $1.3B Deal Led By 3 Firms

    American Industrial Partners has agreed to acquire Avanos Medical Inc. in an all-cash transaction valued at nearly $1.3 billion, a take-private deal steered by three law firms, Avanos announced Tuesday. 

  • April 13, 2026

    Citron's 'Shadowy Gang' Sued Over Short Selling Campaign

    Shareholders of PolarityTE have alleged in a new suit that "members of a shadowy gang of short sellers" conspired to short the biotechnology company's stock through targeted negative media attacks with Citron Research to enrich themselves at the expense of the shareholders, and that they ultimately caused the company's bankruptcy.

  • April 13, 2026

    Obesity Drugmaker Leads 2 Biotech Startups Eyeing IPOs

    Two biotechnology startup companies on Monday filed plans for their public debuts, with obesity-focused Kailera Therapeutics planning to raise an estimated $500 million in its initial public offering and protein biomarker detection platform Alamar Biosciences planning to raise around $150 million.

  • April 13, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court's docket this past week featured a mix of high-stakes settlements, fast-moving deal litigation, governance disputes and a notable post-trial ruling involving fraud-tainted loans.

  • April 13, 2026

    Stikeman-Led GFL Inks $4.6B Waste Management Deal

    GFL Environmental Inc. has agreed to buy Secure Waste Infrastructure Corp. in a CA$6.4 billion ($4.6 billion) deal that would combine one of North America's largest waste haulers with a Western Canadian disposal and industrial waste infrastructure operator.

Expert Analysis

  • SEC Rulemaking Radar: The Debut Of Atkins' 'New Day'

    Author Photo

    The U.S. Securities and Exchange Commission's regulatory flex agenda, published last week, demonstrates a clear return to appropriately tailored and mission-focused rulemaking, with potential new rules applicable to brokers, exchanges and trading, among others, say attorneys at Goodwin.

  • Series

    Law School's Missed Lessons: Adapting To The Age Of AI

    Author Photo

    Though law school may not have specifically taught us how to use generative artificial intelligence to help with our daily legal tasks, it did provide us the mental building blocks necessary for adapting to this new technology — and the judgment to discern what shouldn’t be automated, says Pamela Dorian at Cozen O'Connor.

  • Ch. 11 Ruling Voiding $2M Litigation Funding Sends A Warning

    Author Photo

    A recent Texas bankruptcy court decision that a postconfirmation litigation trust has no obligations to repay a completely drawn down $2 million litigation funding agreement serves as a warning for estate administrators and funders to properly disclose the intended financing, say attorneys at Kleinberg Kaplan.

  • What To Expect As Trump's 401(k) Order Materializes

    Author Photo

    Following the Trump administration’s recent executive order on 401(k) plan investments in alternative assets like cryptocurrencies and real estate, the U.S. Department of Labor and the U.S. Securities and Exchange Commission will need to answer several outstanding questions before any regulatory changes are implemented, say attorneys at Cleary.

  • Demystifying The Civil Procedure Rules Amendment Process

    Author Photo

    Every year, an advisory committee receives dozens of proposals to amend the Federal Rules of Civil Procedure, most of which are never adopted — but a few pointers can help maximize the likelihood that an amendment will be adopted, says Josh Gardner at DLA Piper.

  • With Obligor Ruling, Ohio Justices Calm Lending Waters

    Author Photo

    A recent decision by the Ohio Supreme Court, affirming a fundamental principle that lenders have no duty to disclose material risks to obligors, provides clarity for commercial lending practices in Ohio and beyond, and offers a reminder of the risks presented by guarantee arrangements, says Carrie Brosius at Vorys.

  • Evaluating The SEC's Rising Whistleblower Denial Rate

    Author Photo

    The rising trend of U.S. Securities and Exchange Commission whistleblower award claim denials represents a departure from the SEC's previous track record and may reflect a more conservative approach to whistleblower award determinations under the current administration, say attorneys at Troutman Pepper.

  • Parenting Skills That Can Help Lawyers Thrive Professionally

    Author Photo

    As kids head back to school, the time is ripe for lawyers who are parents to consider how they can incorporate their parenting skills to build a deep, meaningful and sustainable legal practice, say attorneys at Alston & Bird.

  • Unpacking The New Opportunity Zone Tax Incentive Program

    Author Photo

    The One Big Beautiful Bill Act brought several improvements to the opportunity zone tax incentive program that should boost investments in qualified funds, including making it permanent, increasing federal income tax benefits in rural areas, redesignating the qualified zones, and requiring more in-depth reporting, says Marc Schultz at Snell & Wilmer.

  • Series

    Teaching Trial Advocacy Makes Us Better Lawyers

    Author Photo

    Teaching trial advocacy skills to other lawyers makes us better litigators because it makes us question our default methods, connect to young attorneys with new perspectives and focus on the needs of the real people at the heart of every trial, say Reuben Guttman, Veronica Finkelstein and Joleen Youngers.

  • Navigating Brazil's Regulations, Incentives For Green Projects

    Author Photo

    Brazil's evolving environmental regulatory framework and ongoing moves to attract international capital for climate-focused projects may appeal to U.S.-based companies and investors interested in sustainable development — but taking advantage of these opportunities requires careful planning and meaningful stakeholder engagement, says Milena Angulo at Guimarães.

  • Texas Property Law Complicates Financing And Development

    Author Photo

    A new Texas law imposing expansive state-level restrictions on properties owned by entities from designated countries creates a major obstacle for some lenders, developers and other stakeholders, as well as new diligence requirements for foreign companies, say attorneys at Pillsbury.

  • Series

    Adapting To Private Practice: From Texas AUSA To BigLaw

    Author Photo

    As I learned when I transitioned from an assistant U.S. attorney to a BigLaw partner, the move from government to private practice is not without its hurdles, but it offers immense potential for growth and the opportunity to use highly transferable skills developed in public service, says Jeffery Vaden at Bracewell.

  • Advice For 1st-Gen Lawyers Entering The Legal Profession

    Author Photo

    Nikki Hurtado at The Ferraro Law Firm tells her story of being a first-generation lawyer and how others who begin their professional journeys without the benefit of playbooks handed down by relatives can turn this disadvantage into their greatest strength.

  • Structuring Noncompetes In License And Collaboration Deals

    Author Photo

    As companies grappling with coming patent cliffs look to mergers and acquisitions to compensate, contracting parties assessing biopharma license and collaboration agreements should prepare to agree on noncompetes that ensure the parties' respective objectives are met and that their incentives are aligned, both under their collaboration and beyond, says Jeff Jay at Freshfields.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Private Equity archive.